Pfizer Inc.

NYSE:PFE  
43.88
-0.59 (-1.33%)
5:27:05 PM EDT: $43.91 +0.03 (+0.07%)
Products

Vtx-801 Receives U.S. FDA Fast Track Designation For The Treatment Of Wilson Disease

Published: 08/12/2021 11:13 GMT
Pfizer Inc. (PFE) - Vtx-801 Receives U.S. FDA Fast Track Designation for the Treatment of Wilson Disease.
Pfizer Inc - Announced U.S. FDA Has Granted Fast Track Designation to Vtx-801.